Dosage control apparatus

• US 7,896,018 B2
• Filed: 09/14/2009
• Issued: 03/01/2011
• Est. Priority Date: 09/20/2002
• Status: Active Grant

• Current Assignee: Advanced Neuromodulation Systems Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Advanced Neuromodulation Systems Incorporated (Abbott Laboratories Incorporated)
• Inventors: Erickson, John H.
• Primary Examiner(s): Lee; Kevin L
• Application Number:
  US12/559,232
• Publication Number:
  US 20100010479A1
• Time in Patent Office: 533 Days
• Field of Search: 137/614.21, 137/624.11, 137/1, 251/129.21, 251/129.1, 251/129.09, 251/129.15, 604/891.1
• US Class Current: 137/1
• CPC Class Codes: A61M 2005/14208 with a programmable infusion control system, characterised by the infusion program
• CPC Class Codes: A61M 2205/3507 with implanted devices, e.g. external control
• CPC Class Codes: A61M 39/22 Valves or arrangement of valves A61M39/02, A61M39/0247, A61M39/16 take precedence; regulating valves in infusion systems A61M5/16881; in devices worn by the patient for the reception of urine, faeces, catamenial or other discharge, or in colostomy devices A61F5/4405
• CPC Class Codes: A61M 5/14216 Reciprocating piston type
• CPC Class Codes: A61M 5/14276 specially adapted for implantation
• CPC Class Codes: A61M 5/16881 Regulating valves on-off valves, e.g. clamps A61M39/28
• CPC Class Codes: F04B 49/225 with throttling valves or valves varying the pump inlet opening or the outlet opening
• CPC Class Codes: Y10T 137/0318 Processes
• CPC Class Codes: Y10T 137/8242 Electrical
• CPC Class Codes: Y10T 137/86389 Programmer or timer
• CPC Class Codes: Y10T 137/88062 Coaxial oppositely directed seats

Abstract

The invention is directed to a dose control apparatus. The apparatus has two armatures pressed against a valve seat by at least one spring. A coil induces a magnetic field that motivates the armatures against the force of the spring, thereby opening the valve. The armatures may move along a common axis in opposite directions. The apparatus may also include a core located between the armatures and a casing about the coil. The core and casing act to guide the magnetic field, reducing the power requirements for creating the field. Current may be periodically reversed in the coil to provide a degaussing field. In addition, a signal may be produced by the coil in the presence an externally applied magnetic field such as an MRI. An opposing magnetic field may be produced by the coil or the current provided to the coil may be adjusted.

Claims

1. A method for controlling the flow of a fluid from an implantable drug pump device, the method comprising:

storing a therapeutic solution in a reservoir of the implantable drug pump device;

operating a valve component of the implantable drug pump device to control fluid flow from the reservoir and out from the implantable drug pump, wherein valve component comprises (i) two or more opposing armatures within an interior chamber of the valve component of the implantable drug pump device;

(ii) one or more springs placed between the armatures, wherein the springs force the armatures against an armature'"'"'s associated valve seat, wherein during operation the drug pump device induces a magnetic field with at least one coil, the magnetic field motivating the armatures to move along a common axis in opposite directions against the force of the one or more springs providing a path for fluid flow; and

reversing, periodically, the direction of current flow through the at least one coil to form a degaussing field.

2. The method of claim 1, further comprising:

measuring a response from the at least one coil to determine the presence of an externally applied magnetic field.

3. The method of claim 2, further comprising:

inducing with the at least one coil a magnetic field opposing the externally applied magnetic field.

4. The method of claim 1 wherein (i) the valve component is coupled to a bellows, that is separate from the reservoir, and (ii) the bellows is successively filled and emptied of fluid during cycles of the valve component during operation of the implantable drug pump device.

5. The method of claim 1 wherein the valve component is adapted to prevent fluid flow in the presence of an external magnetic field, having a field magnitude greater than a magnitude of a field applied by the implantable drug pump device via the at least one coil, irrespective of a field direction of the external magnetic field relative to the valve component.